Mapping hepatitis C virus types in newly diagnosed patients
Part of Digestive system, Infections clinical trials.
This study looks at people newly diagnosed with hepatitis C to identify the exact type (genotype and subtype) of the virus they have. This information may help doctors choose the best treatment in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years of age or older.
- You must have recently been diagnosed with hepatitis C (found through a blood test showing antibodies).
- You must have an active infection, meaning the virus is present in your blood (HCV RNA positive).
- You must agree to let the researchers use your medical information for the study.
- You must not be under legal guardianship or a court-appointed guardian.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for substances in your blood and immune system that could help doctors find liver cancer earlier. It is for people with liver cancer caused by chronic liver problems like hepatitis C, cirrhosis, or scarring.
This study focuses on screening, treating, and eliminating hepatitis C. It is for people who may be at risk or newly diagnosed, and aims to connect them with care that could help clear the virus.
This trial offers free hepatitis C testing for people who inject or have injected drugs. The goal is to find hidden cases early so they can get treatment.
This study collects a small sample of liver cells to understand how hepatitis B virus behaves in the liver and how the immune system responds. This could help improve future treatments for chronic hepatitis B.
This study tests a simple treatment for Hepatitis C in people experiencing unsheltered homelessness. It aims to help those who are receiving street medicine care and have not been treated before.
This trial studies point-of-care (on-site) testing to find hepatitis C in adults who are at higher risk. If hepatitis C is found, earlier detection can help you get connected to care sooner.
Hear when a new Resistance trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.